Simon Allen's most recent trade in Anebulo Pharmaceuticals Inc was a trade of 70,246 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anebulo Pharmaceuticals Inc | Simon Allen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 70,246 | 70,246 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Simon Allen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 77,457 | 77,457 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Simon Allen | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 625,000 | 625,000 | - | - | Option to purchase Common Stock |